FDA approved Gleevec for gastrointestinal stromal tumors treatment
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
On Jan. 10, 2002, ZymoGenetics, a former Novo Nordisk subsidiary, announced its IPO at $12.00 per share with…
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
In 2002, the banteng, an endangered species, was cloned for the first time. Bantengs, or Bali cattle (Bos…
In 2002, Soy Creations, A Division of Triple ‘F’ Inc, and a corporate partner of Iowa State University’s …
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
In 2002, The Red River Valley Research Corridor was established by U.S. Senator Byron Dorgan. The corridor is…
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
In 2002, the Cancer Center at Baylor College of Medicine, now known as the Dan L Duncan Comprehensive…
In 2002, ViaGen was founded in Austin, Texas in to provide commercial bovine, equine, and porcine gene banking,…
In 2002, The Gateway Building opened at VCU Medical Center, a $39 million dollar structure, opened in March…
On Dec. 17, 2001, the acquisition of Immunex by Amgen was announced for $16 billion in stock and…
On Dec. 12, 2001, the World Health Organization (WHO) confirmed an outbreak of Ebola in Gabon. The WHO…
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
On Nov. 12, 2001, the President George W. Bush signed P.L. 107-67 making appropriations for the Treasury Department,…
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…
On Nov. 5, 2001, following the events of September 11, the Institute of Medicine again called for creation…
On Oct. 8, 2001, Dr. Leland ‘Lee’ Hartwell from Fred Hutchinson Cancer Research Center was awarded the Nobel…
On Sept. 13, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s request for it’s…
On Sept. 11, 2001, the U.S. Centers for Disease Control and Prevention (CDC) learned of a domestic terrorism…
On Sept. 10, 2001, the National Cancer Institute (NCI) launched the Consumer Advocates in Research and Related Activities…
In August 2001, the Alvin J. Siteman Cancer Center was named an National Cancer Institute (NCI) -Designated Cancer…
On Jul. 24, 2001, the largest-ever prostate cancer prevention study was launched by the National Cancer Institute and…
On Jul. 1, 2001, Governor John Kitzhaber signed legislation that expanded Oregon Health & Science University’s (OHSU) mission…
On Jun. 14, 2001, the National Institutes of Health (NIH) dedicated the Louis Stokes Laboratories (Building 50), a…
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
On May 5, 2001, molecular biologist Shirley M. Tilghman was elected the first woman president of Princeton University….
On Apr. 24, 2001, Genome Canada announced $136 million in funding to support 22 large-scale research projects and…
On Mar. 29, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s drug Valcyte (valganciclovir…
On Mar. 7, 2001, Seattle Genetics launched its IPO and sold 7 million shares at $7 per share…